+1 213-510-3499 sales@vparesearch.com
+1 213-510-3499 sales@vparesearch.com
Home/ Healthcare
Industry Coverage

Healthcare Market Research & Reports

Healthcare is being revolutionized by telemedicine, AI‑assisted diagnostics, precision therapeutics, and value‑based care models. VPA Research provides exhaustive analyses of pharmaceutical pipelines, medical device innovation, digital health platforms, and hospital service trends. We track regulatory pathways (FDA, EMA), reimbursement shifts, and patient engagement strategies impacting adoption rates. With granular forecasts by therapy area, device type, and delivery model, our insights support life sciences companies, providers, payers, and investors in navigating a complex, patient‑centric healthcare landscape.

Latest Reports in Healthcare

Explore syndicated research, market outlooks, and sector-specific analysis curated for strategy and growth teams.

2457 reports available

GLP-1 Analogues Market Size, Share and Growth Outlook, 2026: Analysis By Drug Type (Semaglutide, Tirzepatide, Liraglutide, Dulaglutide, Exenatide, Others ), By Application (Type 2 Diabetes Mellitus, Obesity & Weight Management, Cardiovascular Risk Reduction, Emerging Indications ), By Route of Administration (Parenteral , Oral), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies) Companies, and Country Forecast, 2021 to 2034

Global GLP-1 Analogues Market size is forecast to increase from $67.69 Billion in 2026 to $375.92 Billion in 2034 at a CAGR of 23.9% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007367
Pages: 211 Pages

Glove Box Market Size, Share and Growth Outlook, 2026: Analysis By Product Configuration (Benchtop Glove Boxes, Modular Glove Boxes, Portable Glove Boxes), By Material (Stainless Steel, Plastic, Aluminum, Other Materials ), By Application (Chemical Reaction Studies, Contaminant Control, Environmental Stability Testing, Product Examination & Inspection, Battery Production), By End-User (Pharmaceutical & Biotechnology, Electronics & Semiconductor, Academic & Research Institutes, Defense & Aerospace, Nuclear & Radioactive Material Handling) Companies, and Country Forecast, 2021 to 2034

Global Glove Box Market size is forecast to increase from $1.96 Billion in 2026 to $2.56 Billion in 2034 at a CAGR of 3.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007366
Pages: 214 Pages

Glioma Therapeutics Market Size, Share and Growth Outlook, 2026: Analysis By Disease Type (Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Anaplastic Oligoastrocytoma, Other High-Grade Gliomas), By Therapy Type (Chemotherapy, Targeted Therapy, Immunotherapy, Device-Based Therapy, Radiation Therapy), By Grade (Grade I, Grade II, Grade III, Grade IV), By End User (Hospitals, Specialty Clinics, Cancer Research Centers) Companies, and Country Forecast, 2021 to 2034

Global Glioma Therapeutics Market size is forecast to increase from $6.33 Billion in 2026 to $11.21 Billion in 2034 at a CAGR of 7.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007365
Pages: 211 Pages

Glioblastoma Multiforme Therapeutics Market Size, Share and Growth Outlook, 2026: Analysis By Treatment Modality (Surgery, Radiation Therapy, Chemotherapy, Targeted Therapy, Tumor-Treating Fields , Immunotherapy), By Patient Type (Newly Diagnosed GBM, Recurrent GBM), By Age Group (Pediatric, Adult, Geriatric), By End User (Hospitals & Clinics, Ambulatory Surgical Centers) Companies, and Country Forecast, 2021 to 2034

Global Glioblastoma Multiforme Therapeutics Market size is forecast to increase from $3.39 Billion in 2026 to $6.96 Billion in 2034 at a CAGR of 9.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007364
Pages: 215 Pages

Glaucoma Surgery Devices Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Glaucoma Drainage Devices, Minimally Invasive Surgery Devices, Traditional Surgery Devices & Consumables, Laser Systems, Diamond Knives), By Surgery Type (Minimally Invasive Glaucoma Surgery , Conventional Glaucoma Surgery, Laser Surgery), By Target (Trabecular Meshwork, Suprachoroidal Space, Other Targets), By End User (Hospitals, Ophthalmic Clinics, Ambulatory Surgical Centers) Companies, and Country Forecast, 2021 to 2034

Global Glaucoma Surgery Devices Market size is forecast to increase from $1.95 Billion in 2026 to $2.84 Billion in 2034 at a CAGR of 4.8% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007363
Pages: 224 Pages

Glaucoma Market Size, Share and Growth Outlook, 2026: Analysis By Disease Type (Open-Angle Glaucoma , Angle-Closure Glaucoma , Secondary Glaucoma, Congenital Glaucoma, Normal-Tension Glaucoma), By Treatment Type (Pharmaceuticals , Surgeries & Devices ), By Drug Class (Prostaglandin Analogs, Beta-Blockers, Alpha-Adrenergic Agonists, Carbonic Anhydrase Inhibitors, Rho-Kinase , Combination Medications), By End-User (Hospitals & Ophthalmic Clinics, Specialty Eye Centers, Ambulatory Surgical Centers) Companies, and Country Forecast, 2021 to 2034

Global Glaucoma Market size is forecast to increase from $9.64 Billion in 2026 to $14.06 Billion in 2034 at a CAGR of 4.83% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007362
Pages: 224 Pages

Glargine Insulin Market Size, Share and Growth Outlook, 2026: Analysis By Product (Insulin Glargine 100 U, Insulin Glargine 300 U, Combination Formulations), By Drug Type (Branded Reference Biologics, Biosimilars ), By Dosage (Prefilled Injection Pens, Vials & Syringes, Cartridges), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drugstores, Online) Companies, and Country Forecast, 2021 to 2034

Global Glargine Insulin Market size is forecast to increase from $2.98 Billion in 2026 to $4.93 Billion in 2034 at a CAGR of 6.5% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007361
Pages: 226 Pages

Gerontology Market Size, Share and Growth Outlook, 2026: Analysis By Sector (Healthcare & Pharmaceuticals , Assistive & Mobility Devices , Wearable Health & Smart Home Devices , Fitness & Wellness Services , Housing & Care Facilities ), By Service Type (In-Home Care Services, Telehealth & Remote Patient Monitoring, Rehabilitation & Physical Therapy, Palliative & Hospice Care), By Demographic Cohort (65–75 Years, 75–85 Years, 85 Years and Above), By End-User (Individual Consumers , Healthcare Providers & Caregiving Organizations, Government & Non-Profit Organizations) Companies, and Country Forecast, 2021 to 2034

Global Gerontology Market size is forecast to increase from $1.4 Billion in 2026 to $2.68 Billion in 2034 at a CAGR of 8.47% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007360
Pages: 217 Pages

Geriatric Medicine Market Size, Share and Growth Outlook, 2026: Analysis By Therapeutic Category (Analgesics , Antihypertensives , Antidiabetics, Statins , Antidepressants & Antipsychotics, Anticoagulants, Proton Pump Inhibitors ), By Drug Type (Patented Drugs, Generic Drugs), By Route of Administration (Oral , Injectables, Topical, Inhalation), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Direct Sales) Companies, and Country Forecast, 2021 to 2034

Global Geriatric Medicine Market size is forecast to increase from $196.04 Billion in 2026 to $352.24 Billion in 2034 at a CAGR of 7.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007359
Pages: 226 Pages

Geriatric Care Services Market Size, Share and Growth Outlook, 2026: Analysis By Service Type (Home Healthcare Services, Skilled Nursing Facilities, Assisted Living Facilities, Adult Day Care Services, Hospice & Palliative Care Services, Continuing Care Retirement Communities ), By Service Provider (Public, Private Sector, Non-Profit Organizations), By Payment Source (Public Insurance , Private Insurance, Out-of-Pocket Payments), By Application (Heart Diseases, Neurological Disorders , Respiratory Diseases, Diabetes & Metabolic Disorders, Arthritis & Osteoporosis) Companies, and Country Forecast, 2021 to 2034

Global Geriatric Care Services Market size is forecast to increase from $1.49 Billion in 2026 to $2.52 Billion in 2034 at a CAGR of 6.8% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007358
Pages: 213 Pages